Breaking News: Daraxonrasib Approved for Pancreatic Cancer
Today, the U.S. Food and Drug Administration approved daraxonrasib (Rasonque), a groundbreaking new drug for pancreatic cancer that targets...
Progress Against Cancer
Today, the U.S. Food and Drug Administration approved daraxonrasib (Rasonque), a groundbreaking new drug for pancreatic cancer that targets...
A variety of national and local news outlets have highlighted AACR initiatives and experts in recent weeks. Learn about...
The summer issue of Cancer Today includes articles about integrating patient-reported outcomes into clinical research and care, advances in...
During the opening session of the AACR Conference on Drug Discovery and Development, the conference cochairs—Patricia M. LoRusso, DO,...
At the recent AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers, AACR Immediate Past President...
